Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-17FDA Approved: FENOFIBRATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's fenofibrate generic under an original ANDA (ANDA213252).
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting
A completed real-world trial update evaluating atorvastatin effectiveness and safety in cardiology patients, with results posted in 2019.
-
FDA approval · 2019-11-04FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Zhejiang Yongtai Pharmaceutical Co., Ltd.)
FDA approves rosuvastatin calcium as a generic drug (Original Application) by Zhejiang Yongtai Pharmaceutical Co., Ltd.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults [NA]
Clinical trial assessing a beverage intervention for Hispanic adults; completed with posted results in 2019, focusing on obesity and hyperch…
-
FDA approval · 2019-10-22FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited under an ANDA to enable continued mar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-22FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited, allowing the generic product to be m…
-
FDA approval · 2019-10-21FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Cipla USA Inc.,)
The FDA approved Cipla USA Inc.'s Supplemental Application for atorvastatin calcium, making a generic atorvastatin calcium product an approv…
-
FDA approval · 2019-10-16FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for atorvastatin calcium, a generic statin used to treat high cholesterol, unde…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels [NA]
A completed clinical trial evaluated a nutraceutical combination for sub-optimal LDL cholesterol levels; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: Vascular Lifestyle-Intervention and Screening in Pharmacy [NA]
Clinical trial update for a vascular lifestyle-intervention and screening study; status and results not clearly disclosed in the snippet.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia [Phase 3]
A Phase 3 trial comparing alirocumab to ezetimibe on top of statin in high cardiovascular risk patients with hypercholesterolemia in Asia ha…
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia [Phase 4]
A Phase 4 trial comparing Rosuvastatin/Ezetimibe versus Rosuvastatin in patients with diabetes and high cholesterol has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia [Phase 4]
A Phase 4 trial comparing pitavastatin to atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia has completed, wit…
-
FDA approval · 2019-09-13FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved a generic version of colesevelam hydrochloride (Colesevelam HCl) by Bionpharma Inc. under an original ANDA, for lipid-lowering …
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy [Phase 3]
Phase 3 usability study of auto-injector devices for patients with high cardiovascular risk and hypercholesterolemia, completed with results…
-
CLINICAL_TRIALS research · 2019-09-09Clinical Trial Update: Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia [Phase 4]
A Phase 4 trial evaluating the effect of alirocumab on coronary atheroma volume in Japanese patients hospitalized for acute coronary syndrom…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Alirocumab in Patients With Acute Myocardial Infarction [Phase 4]
Phase 4 trial update for alirocumab in patients after acute myocardial infarction, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia [Phase 2]
Phase 2 dose-finding trial evaluating alirocumab in children and adolescents with heterozygous familial hypercholesterolemia has been comple…
-
CLINICAL_TRIALS trial_result · 2019-09-03Clinical Trial Update: Lipid-lowering Therapy Individualization [Phase 4]
A Phase 4 clinical trial update on lipid-lowering therapy individualization for hypercholesterolemia has completed.
-
FDA approval · 2019-08-20FDA Approved: CHOLESTYRAMINE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved a supplemental application for Cholestyramine submitted by Zydus Pharmaceuticals (USA) Inc. under ANDA202901.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population [Phase 4]
Phase 4 clinical trial update assessing lipid-lowering therapies in Vietnamese patients with hypercholesterolemia and chronic kidney disease…
-
FDA approval · 2019-08-07FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Simvastatin by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia [Phase 4]
Phase 4 trial comparing rosuvastatin/ezetimibe versus rosuvastatin in Korean patients with type 2 diabetes mellitus and hypercholesterolemia…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Open Label Study of Long Term Evaluation Against LDL-C Trial [Phase 2]
Open-label Phase 2 trial evaluating long-term LDL-C reduction in hypercholesterolemia.
-
FDA approval · 2019-06-27FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's ezetimibe and simvastatin as an original ANDA application, enabling generic availability.